GT Biopharma, Inc. (GTBP)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | — | ||
| 10-Q/A | Q3-2025 | |||
| 10-Q/A | Q2-2025 | |||
| 10-KLatest | FY-2025 | — | ||
| 10-Q | Q3-2025 | 8-K (2025-11-14) · 99.1 | ||
| 10-Q | Q2-2025 | — | ||
| 10-Q | Q1-2025 | — | ||
| 10-K/A | FY-2024 | |||
| 10-K | FY-2024 | — | ||
| 10-Q | Q3-2024 | — | ||
| 10-Q | Q2-2024 | — | ||
| 10-Q | Q1-2024 | — | ||
| 10-K | FY-2023 | — | ||
| 10-Q | Q3-2023 | — | ||
| 10-Q | Q2-2023 | — |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Statements | ||
| Balance Sheets | ||
| Consolidated Balance Sheets | ||
| Balance Sheets (P) | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations | ||
| Statements of Operations | ||
| Consolidated Statements of Operations (P) | ||
| Statements of Operations (P) | ||
| Statements of Stockholders' Equity (deficit) | ||
| Condensed Statements of Stockholders' Equity (deficit) and Mezzanine Equity (unaudited) | — |
|
| Consolidated Statements of Stockholders' Equity | ||
| Statements of Cash Flows | ||
| Consolidated Statements of Cash Flows | ||
| Notes | ||
| Accounts Payable | ||
| Accounts Payable and Accrued Expenses, and Related Party | — |
|
| Accounts Payable and Related Party | ||
| Award Timing Disclosure | — |
|
| Commitments and Contingencies | ||
| Common Stock Warrants and Options | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Fair Value of Financial Instruments | ||
| Income Tax | — |
|
| Insider Trading Arrangements | ||
| Operating Leases | ||
| Organization and Going Concern Analysis | ||
| Organization and Operations | ||
| Pay Vs Performance Disclosure | ||
| Restatement of Quarterly Financial Statements (unaudited) | — |
|
| Segment Information | ||
| Stockholders Equity | ||
| Stockholders Equity (deficit) | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||
| Warrant Liability | ||